HAEMATOLOGY ARTICLES
Power in partnership: exploring novel light transmission aggregometry
The AUTOPLATE study group has used partnerships to offer improved evaluation of new light transmission aggregometry technology to diagnose platelet function disorders. George Tarpley explains how the group was established and looks at its progress so far.
Overcoming the barriers preventing early diagnosis of multiple myeloma
For a common condition, multiple myeloma is challenging to diagnose, meaning it is often missed in the early stages. Dale Powner examines how it is discovered, recent advances in diagnostic technologies, and what is required to improve clinical practice.
Flow cytometry and AI: shaping the future of haematological diagnostics
Integrating artificial intelligence into flow cytometry workflows offers huge potential benefits both in research and clinical diagnostics. Here, Shahnawaz Memon looks at current and future applications.
Is manual cell counting in CSF specimens a thing of the past?
Cerebrospinal fluid cell counts performed using haemocytometer chamber methods are prone to high interobserver variability and poor reproducibility. Utilising an automated system minimises errors and simplifies the testing process.
Learning from external quality assessment: a case of Hb Knossos
Education is an important aspect of the services provided by UK NEQAS schemes operating across laboratory medicine. Here, Bashori Rahman and Barbara De la Salle provide an example using a rare haemoglobin variant circulated as part of their molecular EQA scheme.
Digital morphology: What advances mean for modern laboratories
Advances in technology mean that moving from microscopes to digital alternatives can now be achieved without sacrificing image quality. But this isn’t about the technology. Professor Gina Zini reflects on the key benefits of digital developments, including better quality screening, saved time for morphologists, better clinical collaboration, improved training, and sharing expertise.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
Distinguishing tumour tissue from normal tissue
Online
8 July, 2025
Introduction to direct immunofluorescence webinar
Online
10 July, 2025
Annual SHOT Symposium
Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025
Introduction to immunocytochemistry webinar
Online
15-16 July, 2025
Cancer – tumour clonality and metastasis webinar
online
7 August, 2025